A synbiotic mixture for the management of infantile colic: A randomized trial

Hanne Delcourt1, Koen Huysentruyt1, Yvan Vandenplas2

  • 1Vrije Universiteit Brussel (VUB), UZ Brussels, KidZ Health Castle, Laarbeeklaan 101, 1090, Brussels, Belgium.

PubMed

Insights

A synbiotic significantly improved infant colic symptoms and caregiver quality of life within one week. This treatment demonstrated efficacy regardless of infant feeding type, offering rapid relief for colicky infants.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Microbiome Research

Background:

  • Infant colic is characterized by prolonged, inconsolable crying in infants.
  • While some probiotics show efficacy in breastfed infants, evidence for synbiotics is less established.
  • Caregiver quality of life is significantly impacted by infant colic.

Purpose of the Study:

  • To evaluate the efficacy of a specific synbiotic (Bactecal D Liquid) in managing infant colic.
  • To assess the impact of the synbiotic on caregiver quality of life and infant crying symptoms.
  • To compare the effectiveness of once-daily versus twice-daily dosing of the synbiotic.

Main Methods:

  • A randomized trial involving 68 infants diagnosed with probable infant colic.
  • Infants received either one or two daily doses of the synbiotic for 28 days.
  • Primary outcome: caregiver quality of life (Likert scale); Secondary outcomes: crying episodes, crying time, gassiness, and physical distress indicators.

Main Results:

  • Caregiver quality of life scores significantly improved from baseline to day 28 (p < 0.001).
  • Significant improvements in quality of life were observed within one week of intervention.
  • Infant crying episodes, crying time, gassiness, and "balling of fists" significantly decreased by day 28 (p < 0.001).
  • No significant difference in efficacy was found between once-daily and twice-daily dosing.

Conclusions:

  • The tested synbiotic is effective in managing infant colic.
  • Rapid symptom improvement and enhanced caregiver quality of life were observed within seven days.
  • The synbiotic's benefits were independent of infant feeding method (breastfeeding, formula, or mixed).

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
136
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
319
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
71.4K
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
170
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147